The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Drake Neil since 2018.
The trader's CIK number is 1698005.
At the time of the last reporting, Drake Neil was the VP Research and Development of Obalon Therapeutics Inc. (stock ticker symbol OBLN).
Also see all insider trading activities at Obalon Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | OBLN | 5,000 | $19,780 | 0 | $0 | 13,926 | $19,747 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-03-15 | OBLN | Buy | 5,000 | 3.96 | 19,780 |
| 2018-02-02 | OBLN | Option Ex | 13,926 | 1.42 | 19,747 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Drake Neil (VP Research and Development of Obalon Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.